SCT
Showing 1 - 25 of 1,123
Hemophilia A With Inhibitor Trial (SCT800 and Daratumumab)
Not yet recruiting
- Hemophilia A With Inhibitor
- SCT800 and Daratumumab
- (no location specified)
May 24, 2023
Head and Neck Squamous Carcinoma Trial in Shanghai (SCT-I10A, SCT200, paclitaxel)
Recruiting
- Head and Neck Squamous Carcinoma
- SCT-I10A
- +3 more
-
Shanghai, ChinaShanghai East Hospital
Sep 22, 2022
Autoimmune Disease Trial in Joondalup, Nedlands (SCT650C)
Not yet recruiting
- Autoimmune Disease
-
Joondalup, Western Australia, Australia
- +2 more
Jun 7, 2023
Sickle Cell Hemoglobinopathies and Bone Health
Active, not recruiting
- Sickle Cell Disease
- Sickle Cell Trait
- Healthy volunteers without SCT
- +2 more
-
Farmington, ConnecticutUConn Health
Nov 1, 2022
Sickle Cell Trait Trial (SCT Documentation and Disclosure Toolkit (SCT-DD))
Not yet recruiting
- Sickle Cell Trait
- SCT Documentation and Disclosure Toolkit (SCT-DD)
- (no location specified)
May 24, 2022
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)
Recruiting
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Imatinib
- +3 more
-
Frankfurt, GermanyDepartment of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023
Non-melanoma Skin Cancer Trial in Sydney, Tugun (Rhenium-SCT)
Recruiting
- Non-melanoma Skin Cancer
- Rhenium-SCT
-
Sydney, New South Wales, Australia
- +1 more
Mar 30, 2022
Multiple Myeloma Trial in Hamburg (allogeneic HSCT)
Completed
- Multiple Myeloma
- allogeneic HSCT
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Sep 1, 2022
Wet Age-related Macular Degeneration Trial (Ranibizumab, SCT510A)
Not yet recruiting
- Wet Age-related Macular Degeneration
- (no location specified)
Jul 28, 2022
Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)
Recruiting
- Myeloid Malignancies
- +3 more
- Cyclophosphamide
- +7 more
-
Houston, TexasM D Anderson Caner Center
Nov 17, 2022
Predict T Cell Chimerism After MSD SCT for SCD?
Recruiting
- Sickle Cell Disease
- Alemtuzumab Injection [Campath]
-
Amsterdam, NetherlandsAmsterdam Medical Centre
Jun 20, 2023
Attention Deficit Disorder, ADHD Trial in New York (Lisdexamfetamine, Placebo)
Completed
- Attention Deficit Disorder
- Attention Deficit Hyperactivity Disorder
- Lisdexamfetamine
- Placebo
-
New York, New York
- +1 more
Oct 18, 2021
HPV InfectioN, HPV-Related Carcinoma Trial in China (Recombinant 14-Valent Human Papillomavirus Vaccine(Insect Cell), )
Active, not recruiting
- HPV InfectioN
- HPV-Related Carcinoma
- Recombinant 14-Valent Human Papillomavirus Vaccine(Insect Cell)
- placebo
-
Nanning, Guangxi, China
- +4 more
Sep 10, 2023
Healthy Trial in Hangzhou (SCT510, Bevacizumab)
Completed
- Healthy
-
Hangzhou, Zhejiang, ChinaFirst Affiliated Hospital of Zhejiang University
Nov 8, 2021
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)
Active, not recruiting
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Gemtuzumab Ozogamicin
-
Valhalla, New YorkNew York Medical College
Sep 26, 2022
Acute Myeloid Leukemia, Myelodysplasia Trial in Roma (Haplo SCT with NK cells, Haplo SCT)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplasia
- Haplo SCT with NK cells
- Haplo SCT
-
Roma, RM, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Oct 14, 2021
Root Canal Obturation Trial in Kuwait (TotalFill Bioceramic Sealer, AH+ Sealer)
Enrolling by invitation
- Root Canal Obturation
- TotalFill Bioceramic Sealer
- AH+ Sealer
-
Kuwait, KuwaitSpecialized Dental Center
Aug 16, 2022
DNA Methylation in Allogeneic Hematopoietic Stem Cell
Recruiting
- Aging
- Stem Cell Transplant Complications
-
Bologna, BO, ItalySt.Orsola-Malpighi University Hospital
Mar 18, 2022
Recurrent Brain Tumor Trial in Houston (biological, other, radiation)
Active, not recruiting
- Recurrent Brain Neoplasm
- Bevacizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
HPV Infection Vaccine Safety SCT1000 Trial in Nanjing (SCT1000, Gardasil®9, )
Recruiting
- HPV Infection Vaccine Safety SCT1000
- SCT1000
- +3 more
-
Nanjing, Jiangsu, ChinaGuanyun Country CDC
Sep 14, 2021
Allogeneic Stem Cell Transplantation in Elderly: 17-years
Completed
- Allogeneic Stem Cell Transplantation in Elderly Patients
-
Brescia, ItalyChair of Hematology and Bone marrow Transplant Unit
Jul 21, 2021
Interventional, Prevention, Randomized Trial in Nanjing (SCT1000, Gardasil®9, Gardasil®)
Recruiting
- Interventional
- +2 more
- SCT1000
- +3 more
-
Nanjing, Jiangsu, ChinaGuanyun Country CDC
Oct 21, 2021
T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)
Terminated
- T-cell Non-Hodgkin Lymphoma
- Cyclophosphamide
- +12 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2023
Sickle Cell Trait Trial in Saint Louis (Exercise)
Recruiting
- Sickle Cell Trait
- Exercise
-
Saint Louis, MissouriSaint Louis University
Jan 11, 2022
Standing Computed Tomography (SCT) Imaging of the Knee Joint
Completed
- Osteoarthritis, Knee
- Standing Computed Tomography
-
Iowa City, IowaUniversity of Iowa
May 21, 2021